Quantcast
Last updated on April 18, 2014 at 17:08 EDT

Latest Centre for Addiction and Mental Health Stories

2010-05-04 13:36:18

Greater levels of a brain protein called monoamine oxidase A (MAO-A) "“ may explain why postpartum blues and clinical depression are so common after childbirth according to an important study published today in the Archives of General Psychiatry. Using an advanced brain imaging method, researchers at the Centre for Addiction and Mental Health discovered that levels of brain MAO-A in healthy women four to six days after delivery were 43% greater as compared to women not recently...

c45418f9f4810a637bf0977624df1f7e
2010-03-01 12:57:09

The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry. The study is co-authored by Drs. Andrea J. Levinson and Zafiris J. Daskalakis of the Centre for Addiction and Mental Health (CAMH). This study shows that compared to healthy individuals, people who have major depressive disorder have altered functions of the neurotransmitter GABA...

2010-01-05 20:32:52

A recent evaluation by the Centre for Addiction and Mental Health (CAMH) shows that online interventions for problem alcohol use can be effective in changing drinking behaviors and offers a significant public health benefit. In the first evaluation of its kind, the study published in Addiction found that problem drinkers provided access to the online screener www.CheckYourDrinking.net, reduced their alcohol consumption by 30% -- or six to seven drinks weekly "“ rates that are comparable...

2009-12-15 23:53:34

A gene involved in some forms of intellectual disability has been identified by scientists at the Centre for Addiction and Mental Health (CAMH), as published this month in The American Journal of Human Genetics. The gene is called TRAPPC9. In the same journal two other international research teams independently confirm the findings of Dr. John B. Vincent, a scientist at CAMH, and his team. "This spotlights the intense interest that genetics is bringing to types of inherited intellectual...

2009-12-08 19:40:06

A key brain protein called monoamine oxidase A (MAO-A) - is highly elevated during clinical depression yet is unaffected by treatment with commonly used antidepressants, according to an important study published today in the Archives of General Psychiatry. The study has important implications for our understanding of why antidepressants don't always work. Researchers at the Centre for Addiction and Mental Health (CAMH) used an advanced brain imaging method to measure levels of the brain...

f36e6c0a8bd39700dc06bcf204d6c8851
2009-03-20 08:13:53

New evidence points to an overlooked risk factor for cancer New evidence by researchers at the Centre for Addiction and Mental Health (CAMH) and researchers in Germany shows that drinking alcohol is the greatest risk factor for acetaldehyde-related cancer. Heavy drinkers may be at increased risk due to exposure from multiple sources. Acetaldehyde is ubiquitous in daily life in Ontario. Widely present in the environment, it is inhaled from the air and tobacco smoke, ingested from alcohol and...

2009-01-18 15:15:00

CAMH study reveals that heritability may not be limited to DNA Scientists at the Centre for Addiction and Mental Health (CAMH) have detected evidence that DNA may not be the only carrier of heritable information; a secondary molecular mechanism called epigenetics may also account for some inherited traits and diseases. These findings challenge the fundamental principles of genetics and inheritance, and potentially provide a new insight into the primary causes of human diseases. Your mother's...

2008-08-20 12:00:57

TORONTO, ONTARIO--(Marketwire - Aug. 20, 2008) - The Canada Foundation for Innovation (CFI) announced today support for large- scale research infrastructure, under its Research Hospital Fund (RHF), for : - Research in major diseases of relevance to the Canadian population, including cancer, cardiovascular diseases, diabetes mellitus/obesity, rheumatology and neurodegenerative disorders at University Health Network (UHN); - Research addressing child health from the molecular level to the...

2008-07-14 09:01:12

TheraGenetics has completed an agreement with the Centre for Addiction and Mental Health in Ontario, Canada, to license intellectual property related to methods and kits for determining the susceptibility of a patient to certain side-effects of anti-depressants. According to TheraGenetics, the strategic expansion into the area of depression underscores the company's commitment to licensing new technologies to build a foundation for future diagnostic tests for the most common central nervous...

2008-07-11 06:00:13

TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced today that it has completed an agreement with the Centre for Addiction and Mental Health (CAMH) in Ontario, Canada, to license intellectual property related to methods and kits for determining the susceptibility of a patient to certain side-effects of...